(Q44619356)

4 December 2017

title

Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats (English)

1 reference

Cardiology and cardiovascular medicine

4 December 2017

main subject

pulmonary hypertension

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

21 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

21 March 2024

author name string

Noritoshi Nagaya

1

1 reference

4 December 2017

Hiroyuki Okumura

2

1 reference

4 December 2017

Masaaki Uematsu

3

1 reference

4 December 2017

Wataru Shimizu

4

1 reference

4 December 2017

Fumiaki Ono

5

1 reference

4 December 2017

Mikiyasu Shirai

6

1 reference

4 December 2017

Hidezo Mori

7

1 reference

4 December 2017

Kunio Miyatake

8

1 reference

4 December 2017

Kenji Kangawa

9

1 reference

4 December 2017

language of work or name

1 reference

1 November 2003

1 reference

full work available at URL

4 December 2017

http://intl-ajpheart.physiology.org/cgi/content/abstract/285/5/H2125

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561683

https://www.physiology.org/doi/pdf/10.1152/ajpheart.00548.2002

21 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

American Journal of Physiology Heart and Circulatory Physiology

21 March 2024

published in

1 reference

4 December 2017

volume

285

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

H2125-31

1 reference

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

The adrenomedullin receptor acts as clearance receptor in pulmonary circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Pulmonary vasodilation to adrenomedullin: a novel peptide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Aerosolised prostacyclin in adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00548.2002

In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells

21 March 2024

8

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma

21 March 2024

9

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells

21 March 2024

10

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Adrenomedullin dilates the pulmonary vascular bed in vivo

21 March 2024

14

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

21 March 2024

17

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure

21 March 2024

19

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure

21 March 2024

20

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats

21 March 2024

22

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension

21 March 2024

23

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat

21 March 2024

24

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

21 March 2024

26

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma

21 March 2024

27

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension

21 March 2024

29

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients <20 years of age

21 March 2024

30

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline

21 March 2024

31

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00548.2002

21 March 2024

Identifiers

1 reference

4 December 2017

1 reference